top of page

Essential4Health

Get Healthy ~ Stay Healthy

Essential4Health

Get Healthy ~ Stay Healthy

medical-practitioner-checking-health-status-patient-blood-pressure-check

PARKINSON'S DISEASE

Description

Parkinson's Disease is a progressive neurodegenerative disorder that primarily affects the brain, leading to difficulties in coordination, balance, and movement. The hallmark symptoms include tremors (uncontrollable shaking), stiffness, and slowness of movement, which can severely impact daily activities. As the disease progresses, individuals may experience a range of non-motor symptoms such as memory problems, depression, and sleep disturbances. Walking and talking can become increasingly difficult over time. Although Parkinson's typically develops in individuals aged 60 or older, some may experience early onset in their 50s or even younger. Early detection and a comprehensive approach to managing both motor and non-motor symptoms are crucial for improving quality of life for those living with Parkinson's. Treatments may include medications, physical therapy, and lifestyle modifications to help slow the progression and manage the condition effectively.

Body System

hands-elderly-woman-parkinson-s-disease

[1] Hantikainen E, Trolle Lagerros Y, Ye W, et al. Dietary Antioxidants and the Risk of Parkinson Disease: The Swedish National March Cohort. Neurology. 2021;96(6):e895-e903.
[2] Zhao X, Zhang M, Li C, Jiang X, Su Y, Zhang Y. Benefits of Vitamins in the Treatment of Parkinson's Disease. Oxid Med Cell Longev. 2019;2019:9426867. Published 2019 Feb 20.
[3] Liu H, Zhang Y, Zhang H, et al. Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study. J Transl Med. 2021;19(1):221. Published 2021 May 24.
[4] Man Anh H, Linh DM, My Dung V, Thi Phuong Thao D. Evaluating Dose- and Time-Dependent Effects of Vitamin C Treatment on a Parkinson's Disease Fly Model. Parkinsons Dis. 2019;2019:9720546. Published 2019 Jan 2.
[5] Ide K, Yamada H, Umegaki K, et al. Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson's disease. Nutrition. 2015;31(2):406-408.
[6] Spencer ES, Pitcher T, Veron G, et al. Positive Association of Ascorbate and Inverse Association of Urate with Cognitive Function in People with Parkinson's Disease. Antioxidants (Basel). 2020;9(10):906. Published 2020 Sep 23.
[7] Quiroga MJ, Carroll DW, Brown TM. Ascorbate- and zinc-responsive parkinsonism. Ann Pharmacother. 2014;48(11):1515-1520.
[8] Fariss MW, Zhang JG. Vitamin E therapy in Parkinson's disease. Toxicology. 2003;189(1-2):129-146.
[9] Schirinzi T, Martella G, Imbriani P, et al. Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence. Front Neurol. 2019;10:148. Published 2019 Feb 26.
[10] Pham DQ, Plakogiannis R. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. Ann Pharmacother. 2005;39(12):2065-2072.
[11] Taghizadeh M, Tamtaji OR, Dadgostar E, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial. Neurochem Int. 2017;108:183-189.
[12] Yang F, Wolk A, Håkansson N, Pedersen NL, Wirdefeldt K. Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts. Mov Disord. 2017;32(11):1631-1636.
[13] Zhang SM, Hernán MA, Chen H, Spiegelman D, Willett WC, Ascherio A. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology. 2002;59(8):1161-1169.
[14] Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med. 2013;62:13-25.
[15] Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK. Glutathione, iron and Parkinson's disease. Biochem Pharmacol. 2002;64(5-6):1037-1048.
[16] Bjørklund G, Peana M, Maes M, Dadar M, Severin B. The glutathione system in Parkinson's disease and its progression. Neurosci Biobehav Rev. 2021;120:470-478.
[17] Martin HL, Teismann P. Glutathione--a review on its role and significance in Parkinson's disease. FASEB J. 2009;23(10):3263-3272.
[18] Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 1994;36(3):348-355.
[19] Mischley LK, Standish LJ, Weiss NS, et al. Glutathione as a Biomarker in Parkinson's Disease: Associations with Aging and Disease Severity. Oxid Med Cell Longev. 2016;2016:9409363.
[20] Perry TL, Godin DV, Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency?. Neurosci Lett. 1982;33(3):305-310.
[21] Wang HL, Zhang J, Li YP, Dong L, Chen YZ. Potential use of glutathione as a treatment for Parkinson's disease. Exp Ther Med. 2021;21(2):125.
[22] Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm (Vienna). 1997;104(6-7):661-677.
[23] Shen L. Associations between B Vitamins and Parkinson's Disease. Nutrients. 2015;7(9):7197-7208. Published 2015 Aug 27.
[24] Murakami K, Miyake Y, Sasaki S, et al. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan. Br J Nutr. 2010;104(5):757-764.
[25] Rojo-Sebastián A, González-Robles C, García de Yébenes J. Vitamin B6 Deficiency in Patients With Parkinson Disease Treated With Levodopa/Carbidopa. Clin Neuropharmacol. 2020;43(5):151-157.
[26] DiFrancisco-Donoghue J, Lamberg EM, Rabin E, Elokda A, Fazzini E, Werner WG. Effects of exercise and B vitamins on homocysteine and glutathione in Parkinson's disease: a randomized trial. Neurodegener Dis. 2012;10(1-4):127-134.
[27] Xie Y, Feng H, Peng S, Xiao J, Zhang J. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis. Neurosci Lett. 2017;636:190-195.
[28] Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59(10):1541-1550.
[29] Mischley LK, Allen J, Bradley R. Coenzyme Q10 deficiency in patients with Parkinson's disease. J Neurol Sci. 2012;318(1-2):72-75.
[30] Liu J, Wang L, Zhan SY, Xia Y. Coenzyme Q10 for Parkinson's disease. Cochrane Database Syst Rev. 2011;(12):CD008150. Published 2011 Dec 7.
[31] Müller T, Büttner T, Gholipour AF, Kuhn W. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett. 2003;341(3):201-204.
[32] Shults CW. Therapeutic role of coenzyme Q(10) in Parkinson's disease. Pharmacol Ther. 2005;107(1):120-130.
[33] Cleren C, Yang L, Lorenzo B, et al. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem. 2008;104(6):1613-1621.
[34] Yoritaka A, Kawajiri S, Yamamoto Y, et al. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease. Parkinsonism Relat Disord. 2015;21(8):911-916.
[35] Cucca A, Mazzucco S, Bursomanno A, et al. Amino acid supplementation in l-dopa treated Parkinson's disease patients. Clin Nutr. 2015;34(6):1189-1194.
[36] Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson's disease: review and meta-analysis. Eur J Neurol. 2020;27(11):2336-2347.
[37] Kidd PM. Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern Med Rev. 2000;5(6):502-529.
[38] Birkmayer JG, Vrecko C, Volc D, Birkmayer W. Nicotinamide adenine dinucleotide (NADH)--a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application. Acta Neurol Scand Suppl. 1993;146:32-35.
[39] Kuhn W, Müller T, Winkel R, et al. Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis. J Neural Transm (Vienna). 1996;103(10):1187-1193.
[40] Birkmayer W, Birkmayer GJ, Vrecko K, Mlekusch W, Paletta B, Ott E. The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients. J Neural Transm Park Dis Dement Sect. 1989;1(4):297-302.
[41] Swerdlow RH. Is NADH effective in the treatment of Parkinson’s disease? Drugs Aging 1998;13:263-268.
[42] Birkmayer W, Birkmayer GJ. Nicotinamidadenindinucleotide (NADH): The new approach in the therapy of Parkinson’s disease. Ann Clin Lab Sci 1989;19:38-43.
[43] Birkmayer W, et al. The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients. Adv Neurol 1990;53:545-549.
[44] Birkmayer JG, et al. Nicotinamide adenine dinucleotide (NADH)—a new therapeutic approach to Parkinson’s disease. Comparison of oral and parenteral application. Acta Neurol Scand Suppl 1993;146.
[45] Dizdar N, et al. Treatment of Parkinson’s disease with NADH. Acta Neurol Scand 1994;90:345-347.
[46] Du K, Liu MY, Zhong X, Wei MJ. Decreased circulating Zinc levels in Parkinson's disease: a meta-analysis study. Sci Rep. 2017;7(1):3902. Published 2017 Jun 20.
[47] Forsleff L, Schauss AG, Bier ID, Stuart S. Evidence of functional zinc deficiency in Parkinson's disease. J Altern Complement Med. 1999;5(1):57-64.
[48] Qureshi GA, Qureshi AA, Memon SA, Parvez SH. Impact of selenium, iron, copper and zinc in on/off Parkinson's patients on L-dopa therapy. J Neural Transm Suppl. 2006;(71):229-236.
[49] Wojtunik-Kulesza K, Oniszczuk A, Waksmundzka-Hajnos M. An attempt to elucidate the role of iron and zinc ions in development of Alzheimer's and Parkinson's diseases. Biomed Pharmacother. 2019;111:1277-1289.
[50] Sun H, Liu X, Ge H, Wang T, Wang Y, Li W. Association Between Serum Zinc Levels and the Risk of Parkinson's Disease: a Meta-Analysis. Biol Trace Elem Res. 2017;179(1):45-51.
[51] Anirudhan A, Angulo-Bejarano PI, Paramasivam P, et al. RPL6: A Key Molecule Regulating Zinc- and Magnesium-Bound Metalloproteins of Parkinson's Disease. Front Neurosci. 2021;15:631892. Published 2021 Mar 11.
[52] Mohammed NA, Abdou HM, Tass MA, Alfwuaires M, Abdel-Moneim AM, Essawy AE. Oral Supplements of Ginkgo biloba Extract Alleviate Neuroinflammation, Oxidative Impairments and Neurotoxicity in Rotenone-Induced Parkinsonian Rats. Curr Pharm Biotechnol. 2020;21(12):1259-1268.
[53] Kim MS, Lee JI, Lee WY, Kim SE. Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease. Phytother Res. 2004;18(8):663-666.
[54] Rojas P, Montes P, Rojas C, Serrano-García N, Rojas-Castañeda JC. Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: therapeutic perspectives. Nutrition. 2012;28(11-12):1081-1088.
[55] Yang SF, Wu Q, Sun AS, Huang XN, Shi JS. Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin. 2001;22(12):1089-1093.
[56] Yu D, Zhang P, Li J, et al. Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson's disease. J Pharm Anal. 2021;11(2):220-231.
[57] Peterson AL. A review of vitamin D and Parkinson's disease. Maturitas. 2014;78(1):40-44.
[58] Sleeman I, Aspray T, Lawson R, et al. The Role of Vitamin D in Disease Progression in Early Parkinson's Disease. J Parkinsons Dis. 2017;7(4):669-675.
[59] Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EM. Systematic Review of the Relationship between Vitamin D and Parkinson's Disease. J Parkinsons Dis. 2016;6(1):29-37.
[60] Vinh Quôc Luong K, Thi Hoàng Nguyên L. Vitamin D and Parkinson's disease. J Neurosci Res. 2012;90(12):2227-2236.
[61] Newmark HL, Newmark J. Vitamin D and Parkinson's disease--a hypothesis. Mov Disord. 2007;22(4):461-468.
[62] Bousquet M, Calon F, Cicchetti F. Impact of omega-3 fatty acids in Parkinson's disease. Ageing research reviews. 2011 Sep 1;10(4):453-63.
[63] Li P, Song C. Potential treatment of Parkinson’s disease with omega-3 polyunsaturated fatty acids. Nutritional neuroscience. 2022 Jan 2;25(1):180-91.
[64] Di Rocco A, Rogers JD, Brown R, Werner P, Bottiglieri T. S‐adenosyl‐methionine improves depression in patients with Parkinson's disease in an open‐label clinical trial. Movement Disorders: Official Journal of the Movement Disorder Society. 2000 Nov;15(6):1225-9.
[65] Carrieri PB, Indaco A, Gentile S, Troisi E. S-adenosylmethionine treatment of depression in patients with Parkinson's disease: A double-blind, crossover study versus placebo. Current therapeutic research. 1990 Jul.
[66] De Araujo DP, Lobato RD, Cavalcanti JR, Sampaio LR, Araújo PV, Silva MC, Neves KR, Fonteles MM, Sousa FC, Vasconcelos SM. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson’s disease: a review. International Journal of Neuroscience. 2011 Jan 7;121(2):51-7.
[67] Zheng Q, Ma P, Yang P, Zhai S, He M, Zhang X, Tu Q, Jiao L, Ye L, Feng Z, Zhang C. Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson’s disease. Neuroscience letters. 2023 Jul 27;810:137346.
[68] Zhang H, Jia H, Liu J, Ao N, Yan B, Shen W, Wang X, Li X, Luo C, Liu J. Combined R‐α–lipoic acid and acetyl‐L‐carnitine exerts efficient preventative effects in a cellular model of Parkinson’s disease. Journal of cellular and molecular medicine. 2010 Jan;14(1‐2):215-25.
[69] Burks S, Raymick J, Robinson B, Hanig J, Sarkar S. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson’s disease mouse model: Endothelial and microglial effects. Neuroscience Letters. 2019 Jun 11;703:86-95.
[70] Nebrisi EE. Neuroprotective activities of curcumin in Parkinson’s disease: a review of the literature. International journal of molecular sciences. 2021 Oct 18;22(20):11248.
[71] B Mythri R, M Srinivas Bharath M. Curcumin: a potential neuroprotective agent in Parkinson's disease. Current pharmaceutical design. 2012 Jan 1;18(1):91-9.
[72] Zahiruddin S, Basist P, Parveen A, Parveen R, Khan W, Ahmad S. Ashwagandha in brain disorders: A review of recent developments. Journal of ethnopharmacology. 2020 Jul 15;257:112876.
[73] RajaSankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease. Neuroscience letters. 2009 Apr 17;454(1):11-5.
[74] Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson’s disease. Drugs & aging. 2003 Aug;20:711-21.
[75] Weinreb O, Mandel S, Amit T, Youdim MB. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. The Journal of nutritional biochemistry. 2004 Sep 1;15(9):506-16.
[76] Doaee P, Rajaei Z, Roghani M, Alaei H, Kamalinejad M. Effects of Boswellia serrata resin extract on motor dysfunction and brain oxidative stress in an experimental model of Parkinson’s disease. Avicenna journal of phytomedicine. 2019 May;9(3):281.
[77] Rajabian A, Sadeghnia H, Fanoudi S, Hosseini A. Genus Boswellia as a new candidate for neurodegenerative disorders. Iranian journal of basic medical sciences. 2020 Mar;23(3):277.
[78] N. P D, Kondengadan MS, Sweilam SH, Rahman MH, Muhasina KM, Ghosh P, Bhargavi D, Palati DJ, Maiz F, Duraiswamy B. Neuroprotective role of coconut oil for the prevention and treatment of Parkinson’s disease: Potential mechanisms of action. Biotechnology and Genetic Engineering Reviews. 2022 Oct 10:1-33.
[79] Ibrahim KS, El-Sayed EM. Beneficial effects of coconut oil in treatment of Parkinson’s disease. Neurophysiology. 2020 Mar;52(2):169-75.
[80] Patricio F, Morales-Andrade AA, Patricio-Martínez A, Limón ID. Cannabidiol as a therapeutic target: evidence of its neuroprotective and neuromodulatory function in Parkinson’s disease. Frontiers in Pharmacology. 2020 Dec 15;11:595635.
[81] Junior NC, dos- Santos-Pereira M, Guimarães FS, Del Bel E. Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and L-DOPA-induced dyskinesia. Neurotoxicity research. 2020 Jan;37:12-29.
[82] Shulman LM, Wen X, Weiner WJ, Bateman D, Minagar A, Duncan R, Konefal J. Acupuncture therapy for the symptoms of Parkinson's disease. Movement disorders. 2002 Jul;17(4):799-802.
[83] Pereira CR, Machado J, Rodrigues J, de Oliveira NM, Criado MB, Greten HJ. Effectiveness of Acupuncture in Parkinson’s Disease Symptoms—A Systematic Review. InHealthcare 2022 Nov 21 (Vol. 10, No. 11, p. 2334). MDPI.
[84] Mirelman A, Herman T, Nicolai S, Zijlstra A, Zijlstra W, Becker C, Chiari L, Hausdorff JM. Audio-biofeedback training for posture and balance in patients with Parkinson's disease. Journal of neuroengineering and rehabilitation. 2011 Dec;8:1-7.
[85] Thompson M, Thompson L. Biofeedback for movement disorders (dystonia with Parkinson's disease): theory and preliminary results. Journal of Neurotherapy. 2002 Sep 1;6(4):51-70.
[86] Pinto C, Salazar AP, Marchese RR, Stein C, Pagnussat AS. The effects of hydrotherapy on balance, functional mobility, motor status, and quality of life in patients with Parkinson disease: a systematic review and meta‐analysis. PM&R. 2019 Mar;11(3):278-91.
[87] Volpe D, Giantin MG, Maestri R, Frazzitta G. Comparing the effects of hydrotherapy and land-based therapy on balance in patients with Parkinson’s disease: a randomized controlled pilot study. Clinical rehabilitation. 2014 Dec;28(12):1210-7.
[88] Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, Maddalozzo G, Batya SS. Tai chi and postural stability in patients with Parkinson's disease. New England Journal of Medicine. 2012 Feb 9;366(6):511-9.
[89] Yang Y, Li XY, Gong L, Zhu YL, Hao YL. Tai Chi for improvement of motor function, balance and gait in Parkinson's disease: a systematic review and meta-analysis. PloS one. 2014 Jul 21;9(7):e102942.
[90] Sharma NK, Robbins K, Wagner K, Colgrove YM. A randomized controlled pilot study of the therapeutic effects of yoga in people with Parkinson's disease. International journal of yoga. 2015 Jan 1;8(1):74-9.
[91] Mailankody P, Varambally S, Thennarasu K, Pal PK. The rationale of yoga in Parkinson's disease: a critical review. Neurology India. 2021 Sep 1;69(5):1165-75.

1. Vitamin C: Vitamin C acts as a powerful antioxidant, neutralizing oxidative stress in neurons, which helps safeguard brain cells from damage. This neuroprotective action may support overall neuronal health and function.

2. Vitamin E: Vitamin E provides antioxidant protection against oxidative damage in brain cells, helping reduce the risk of neurodegenerative conditions. Moderate consumption of vitamin E supports long-term neuronal health.

3. Glutathione: Glutathione is a crucial antioxidant that neutralizes reactive oxygen species (ROS), protecting neurons from oxidative stress. Low glutathione levels are linked to early neurodegenerative progression, highlighting its importance for brain cell health.

4. Vitamin B Complex: Vitamin B complex supports dopamine production and neurotransmitter balance, essential for brain health. Deficiencies in vitamins B6, B9, and B12 may impair the breakdown of homocysteine, a risk factor for neurodegeneration.

5. Zinc: Zinc helps protect neurons by regulating neurotransmitter activity and reducing oxidative stress. Its role in maintaining overall brain health is essential for supporting cognitive function and mitigating neurodegenerative risks.

6. Vitamin D: Vitamin D3 supports neuroprotective processes by regulating neurotrophic factors that promote neuronal survival. It also plays a role in reducing inflammation, supporting brain health and reducing neurodegeneration risk.

7. Coenzyme Q10: Coenzyme Q10 boosts energy production in brain cells by enhancing mitochondrial function. Its neuroprotective properties may help preserve dopamine-producing neurons and support overall brain health.

8. Amino Acids: Amino acids are vital for neurotransmitter synthesis and brain health. Ensuring an adequate supply prevents deficiencies that can impair neurological function, supporting cognitive and motor functions.

9. NADH: NADH stimulates dopamine production in the brain, potentially alleviating symptoms related to dopamine deficiency. Its role in supporting mitochondrial function may improve cognitive and motor performance.

10. Omega 3: Omega-3 fatty acids, particularly EPA and DHA, support neuronal health by reducing inflammation and oxidative stress. Their neuroprotective effects can enhance motor function and cognitive health.

11. S-Adenosylmethionine [SAMe]: SAM-e aids neurotransmitter synthesis, including dopamine, and offers neuroprotective benefits by reducing oxidative stress and inflammation in the brain. It helps support mood and motor function.

12. Alpha-Lipoic Acid: Alpha-lipoic acid protects neurons by reducing oxidative stress and supporting mitochondrial function. It enhances energy production in brain cells, helping maintain motor and cognitive function.

13. Acetyl-L-Carnitine [ALC]: Acetyl-L-carnitine supports mitochondrial energy production, improving both motor and cognitive function. Its neuroprotective effects help reduce oxidative damage and promote neurotransmitter balance.

1. Ginkgo Biloba Extract: Ginkgo biloba enhances antioxidant activity, protecting brain cells from oxidative stress. Its neuroprotective properties support brain function by inhibiting free radicals and improving circulation.

2. Curcumin: Curcumin reduces neuroinflammation and oxidative stress, protecting neurons from damage. Its strong anti-inflammatory effects support overall brain health and may slow the progression of neurodegenerative conditions.

3. Ashwagandha: Ashwagandha enhances neuronal health by reducing oxidative stress and inflammation. This adaptogen supports nerve function and improves cognitive health by stabilizing oxidative stress markers.

4. Green Tea Extract: Green tea, rich in catechins like EGCG, protects neurons by reducing oxidative stress and inflammation. It promotes detoxification, supports brain cell repair, and aids in neuroprotection.

5. Boswellia Serrata Extract: Boswellia serrata’s anti-inflammatory properties reduce neuroinflammation and support neuronal health. By inhibiting harmful inflammatory mediators, it protects neurons from damage and may reduce motor dysfunction.

1. Nutritional Yeast: Nutritional yeast, rich in B vitamins, supports overall brain health by maintaining nerve function and promoting antioxidant activity. Its high B12 content helps protect against neurodegeneration.

2. Coconut Oil: Extra virgin coconut oil contains medium-chain triglycerides (MCTs) that can be converted into ketones, providing an alternative energy source for brain cells. Its neuroprotective properties, combined with antioxidant effects, help reduce oxidative stress.

3. CBD Oil: CBD oil possesses neuroprotective and anti-inflammatory properties, helping to manage motor symptoms, reduce tremors, and improve sleep. It may also alleviate non-motor symptoms, such as anxiety and pain.

1. Acupuncture: Acupuncture stimulates points like LI4 (Hegu) on the hand and ST36 (Zusanli) below the knee, improving circulation and reducing inflammation. It helps manage both motor and non-motor symptoms, including pain and tremors.

2. Biofeedback: Biofeedback helps improve motor functions by teaching individuals to control physiological processes, such as muscle tension and heart rate, through real-time data monitoring, reducing stress and improving movement.

3. Hydrotherapy: Hydrotherapy enhances motor function and flexibility by reducing joint stress through buoyancy. Warm water therapy improves movement, relieves stiffness, and promotes relaxation.

4. Tai Chi: Tai chi promotes balance, stability, and coordination through slow, controlled movements. It improves motor function, reduces the risk of falls, and enhances overall well-being.

5. Yoga: Yoga improves motor function, balance, and flexibility through gentle stretching and mindful breathing. Regular practice reduces stress, enhances physical function, and promotes mental clarity.

Supplements

Plant Extracts

Natural Compounds

Alternative Treatments

Symptoms & Signs

Causes

Neurotoxins, Oxidative Stress, High Homocysteine Levels, Gut Dysbiosis

Books That You May Want To Read

How Nutrients Function

Amino Acids: Amino acids serve as the building blocks of proteins, crucial for muscle growth and repair. Additionally, they play key roles in maintaining proper pH levels, storing nitrogen, synthesizing hormones, and facilitating enzymatic reactions.


Antioxidants: Antioxidants protect cells from oxidative stress caused by free radicals, potentially reducing the risk of chronic diseases such as cancer and cardiovascular ailments. They safeguard DNA integrity, slow down aging processes, and support overall cellular health.


Enzymes and Coenzymes: Enzymes catalyze biochemical reactions, while coenzymes assist in these processes by binding temporarily to enzymes. Together, they regulate digestion, energy production, immune responses, and various metabolic pathways.


Fatty Acids: Fatty acids serve as energy sources, structural components of cell membranes, and precursors to signaling molecules. Essential fatty acids, like omega-3 and omega-6, play critical roles in brain function, cardiovascular health, and inflammation regulation.


Herbal Extracts: Herbal extracts contain bioactive compounds with various medicinal properties, including antioxidant, anti-inflammatory, and antimicrobial effects. They have been used traditionally to support digestion, immunity, and overall health.


Minerals: Minerals are essential for various physiological functions, including bone health, nerve transmission, and enzyme activity. They support overall health by ensuring proper cellular function and metabolic processes.


Other Nutrients: Other nutrients encompass a wide array of essential compounds crucial for various physiological functions. This category includes neurotransmitters and their precursors, which facilitate nerve signaling and are vital for central nervous system function. Additionally, naturally occurring structural components and biological detergents, such as phospholipids and bile salts, play critical roles in tissue repair, fat digestion, and overall bodily function. Phospholipids contribute to cell membrane integrity and fat emulsification, while bile salts are key to digesting and absorbing dietary fats. Hormones and their precursors regulate numerous physiological processes, including metabolism, growth, and reproduction. Furthermore, naturally occurring chemicals and metals play pivotal roles in enzymatic reactions, immune function, and overall health maintenance.


Vitamins: Vitamins are essential micronutrients that play diverse roles in supporting cellular processes, immune function, and overall health. They must be obtained through diet or supplementation to ensure proper bodily function.

Nutrients Explained In Nutritional Guide

Podcast Episodes To Listen To

Educational Videos To Learn From

Functional Lab Tests That You Might Consider

References

Things To Do

The dietary recommendations for Parkinson's disease are:


  • a whole-foods-based diet that includes fresh vegetables, fruits, meat, fish, legumes, whole grains, and healthy fats.

  • a high-fiber and low-carbohydrate diet [such as healthy ketogenic or paleo diets]. Dietary ketosis has been found to improve cognition and reduce the intensity of tremors in people with Parkinson's disease.

  • Limit the intake of protein to 50 g a day for men and 40 g a day for women. Lower protein consumption can help inhibit tremors.

  • incorporate antioxidant-rich foods and CoQ 10. Antioxidants help counteract the effects of oxidative stress in the body. Due to the decreased levels of gluthation, a potent antioxidant, in PD, it is especially crucial.

  • include anti-inflammatory foods. They will help manage inflammatory processes in the body.

  • consume foods high in B vitamins. They have an effect on cognitive and brain functioning in PD.

  • incorporate foods rich in vitamin D and omega-3 fatty acids. They are associated with a reduced risk of developing PD and improved symptoms in those who already have it.

  • Coffee can help slow down the progression of PD, particularly motor function.

  • Consume prebiotic and probiotic foods to strengthen your gut and improve your symptoms.

  • Make your meals easy to chew. Take smaller bites to avoid choking.

  • Stay hydrated. Drink quality mineral water. 


Additionally, apply the following:


  • Get quality sleep and take care of your sleep hygiene. Use blue-light-blocking glasses and limit screen time in the evening.

  • exercise regularily. Physical activity is essential for motor functioning and improves neuroplasticity.

  • practice stress reduction techniques, such as mindfulness, meditation, prayer, and yoga.

  • reduce toxin exposure. When shopping, opt for organic produce, toxin-free cleaning supplies, laundry detergents, body, hair, skin, and oral care products.

  • Exchange plastic tupperware with glass containers.

  • Check your home for mold.

  • Install air purifiers in your home. They can be especially helpful if you live in an urban area.

  • Go outside daily, get some fresh air, and get some sun exposure to boost your vitamin D levels.

  • Ask for help whenever it is needed.

Things To Avoid

Avoid the following foods:


  • processed, junk, and fast foods. Their ingredients contribute to poor gut health, inflammation, impaired cognitive function, and more.

  • sugar, artificial sweeteners, sugary snacks, drinks, desserts, candy, etc. They put your intestinal health in imbalance, cause inflammation, and can lead to insulin resistance and diabetes.

  • low-fat dairy, which is associated with an increased risk of developing PD.

  • gluten. Gluten sensitivity very often manifests as neurological impairments.

  • foods and food constituents you are allergic to, sensitive to, or intolerant of.

  • refined carbohydrates. Not only do they drive blood glucose levels up, but they are also more difficult to digest and devoid of fiber.

  • trans fats, which are inflammatory and contribute to the severity of symptoms.

  • Alcohol consumption can worsen the symptoms.

  • Advanced glycation end products [AGEs] found in processed, deep-fried, grilled, and smoked foods contribute to the progression of Parkinson's disease.

  • too much protein, which makes the symptoms of PD, especially tremors, worse.


In addition, avoid the following:


  • circadian rhythm disruption, such as blue light exposure, shift work, and insomnia.

  • environmental toxins, such as mold, pesticides, herbicides, air pollution, etc.

  • non-stick cooking pans and plastics.

  • fluoride, which has negative effects on nerve cells.

  • sedentary lifestyle.

  • social isolation, which may lead to mental health problems.

  • chronic stress.

bottom of page